Publications internationales
Nous mettons ici à votre disposition une sélection de publications scientifiques en rapport avec l'immunothérapie IOZK.
Vous pouvez effectuer une sélection par type de tumeur et par méthode à l'aide des filtres ou saisir des termes de recherche.
Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial
Improved efficacy of therapeutic vaccination with dendritic cells pulsed with tumor cell lysate against hepatocellular carcinoma by introduction of 2 tandem repeats of microbial HSP70 peptide epitope 407-426 and OK-432
Induction of tolerogenic dendritic cells by IL-6-secreting CT26 colon carcinoma
Importance of retinoic acid-inducible gene I and of receptor for type I interferon for cellular resistance to infection by Newcastle disease virus
Current vaccination strategies for prostate cancer
Proving the principle: dendritic cell-based vaccines in urogenital cancers
Dendritic cell-based vaccines positively impact natural killer and regulatory T cells in hepatocellular carcinoma patients
Regional hyperthermia combined with chemoradiotherapy in primary or recurrent locally advanced pancreatic cancer : an open-label comparative cohort trial
A gynecologic oncology group phase II trial of two p53 peptide vaccine approaches: subcutaneous injection and intravenous pulsed dendritic cells in high recurrence risk ovarian cancer patients
Current immunotherapeutic approaches in pancreatic cancer
Immunotherapy in human glioblastoma
Differentiation of CD8+ T cells into effector cells is enhanced by physiological range hyperthermia
Apoptin enhances the oncolytic properties of Newcastle disease virus
HER2-based recombinant immunogen to target DCs through FcγRs for cancer immunotherapy
Immunotherapy for prostate cancer: biology and therapeutic approaches
Synergistic effect of hyperthermia and neferine on reverse multidrug resistance in adriamycin-resistant SGC7901/ADM gastric cancer cells
Pulsing with blast cell lysate or blast-derived total RNA reverses the dendritic cell-mediated cytotoxic activity of cytokine-induced killer cells against allogeneic acute myelogenous leukemia cells
Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?
Antigen-specific immunity and tumor inflammation after vaccination with BPX-101, a drug-activated dendritic cell vaccine for metastatic castration-resistant prostate cancer (mCRPC).
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1